UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fluoxetine Treatment for Prevention of Relapse of Depression in Children and Adolescents: A Double-Blind, Placebo-Controlled Study

Journal of the American Academy of Child and Adolescent Psychiatry, 2004-11, Vol.43 (11), p.1397-1405

2004

Volltextzugriff (PDF)

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression

Journal of affective disorders, 2000-08, Vol.59 (2), p.119-126

2000

Volltextzugriff (PDF)

Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia

Journal of clinical psychopharmacology, 2002-04, Vol.22 (2), p.137-147

2002

Volltextzugriff (PDF)

Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment

The journal of clinical psychiatry, 2000-11, Vol.61 (11), p.863-867

2000

Volltextzugriff (PDF)

Identifying Potential Adverse Events Dose-Response Relationships Via Bayesian Indirect and Mixed Treatment Comparison Models

Journal of biopharmaceutical statistics, 2013-01, Vol.23 (1), p.26-42

2013

Volltextzugriff (PDF)

Fluoxetine and adult suicidality revisited: an updated meta-analysis using expanded data sources from placebo-controlled trials

Journal of clinical psychopharmacology, 2007-12, Vol.27 (6), p.682-686

2007

Volltextzugriff (PDF)

Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: An updated meta-analysis

Clinical therapeutics, 2000-11, Vol.22 (11), p.1319-1330

2000

Volltextzugriff (PDF)

Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study

Journal of child and adolescent psychopharmacology, 2006-02, Vol.16 (1-2), p.207

2006

Volltextzugriff (PDF)

Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day dose

The journal of clinical psychiatry, 2000-10, Vol.61 (10), p.722-728

2000

Volltextzugriff (PDF)

No gender differences in placebo responses of patients with major depressive disorder

Biological psychiatry (1969), 2001-01, Vol.49 (2), p.158-160

2001

Volltextzugriff (PDF)

Defining Treatment-Emergent Adverse Events with the Medical Dictionary for Regulatory Activities (MedDRA)

Drug information journal, 2001-10, Vol.35 (4), p.1289-1299

2001

Volltextzugriff (PDF)

Fluoxetine 40–60 mg versus Fluoxetine 20 mg in the Treatment of Children and Adolescents with a Less-Than-Complete Response to Nine-Week Treatment with Fluoxetine 10–20 mg: APilot Study

Journal of child and adolescent psychopharmacology, 2006-03, Vol.16 (1-2), p.207-217

2006

Volltextzugriff (PDF)

Interpreting melanin-based coloration through deep time: a critical review

Proceedings of the Royal Society. B, Biological sciences, 2015-08, Vol.282 (1813), p.20150614-20150614

2015

Volltextzugriff (PDF)

Identification of Highly Active Fe Sites in (Ni,Fe)OOH for Electrocatalytic Water Splitting

Journal of the American Chemical Society, 2015-01, Vol.137 (3), p.1305-1313

2015

Volltextzugriff (PDF)

GRK3 deficiency elicits brain immune activation and psychosis

Molecular psychiatry, 2021-11, Vol.26 (11), p.6820-6832

2021

Volltextzugriff (PDF)

Correction: GRK3 deficiency elicits brain immune activation and psychosis

Molecular psychiatry, 2022-03, Vol.27 (3), p.1855-1855

2022

Volltextzugriff (PDF)

Cardiometabolic Polygenic Risk Scores and Osteoarthritis Outcomes: A Mendelian Randomization Study Using Data From the Malmö Diet and Cancer Study and the UK Biobank

Arthritis & rheumatology (Hoboken, N.J.), 2019-06, Vol.71 (6), p.925-934

2019

Volltextzugriff (PDF)

Allergen immunotherapy and/or biologicals for IgE‐mediated food allergy: A systematic review and meta‐analysis

Allergy (Copenhagen), 2022-06, Vol.77 (6), p.1852-1862

2022

Volltextzugriff (PDF)

PPARα is a key regulator of hepatic FGF21

Biochemical and biophysical research communications, 2007-08, Vol.360 (2), p.437-440

2007

Volltextzugriff (PDF)

A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes

Diabetes (New York, N.Y.), 2018-07, Vol.67 (7), p.1414-1427

2018

Volltextzugriff (PDF)

Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults

PloS one, 2015-04, Vol.10 (4), p.e0118486-e0118486

2015

Volltextzugriff (PDF)

Enhancing the alignment of the preclinical and clinical stroke recovery research pipeline: Consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable translational working group

International journal of stroke, 2017-07, Vol.12 (5), p.462-471

2017

Volltextzugriff (PDF)

Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia

The journal of clinical endocrinology and metabolism, 2022-08, Vol.107 (8), p.e3241-e3253

2022

Volltextzugriff (PDF)

Lymphocytes Contribute to the Pathophysiology of Neonatal Brain Injury

Frontiers in neurology, 2018-03, Vol.9, p.159-159

2018

Volltextzugriff (PDF)

Murine astrotactins 1 and 2 have a similar membrane topology and mature via endoproteolytic cleavage catalyzed by a signal peptidase

The Journal of biological chemistry, 2019-03, Vol.294 (12), p.4538-4545

2019

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(74)
Tagungsberichte
(2)

Sprache

Englisch
(75)
Japanisch
(16)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(46)
Humans
(42)
Medicin Och Hälsovetenskap
(31)
Male
(28)
Female
(23)
Biological And Medical Sciences
(22)
Adult
(17)
Medical Sciences
(17)
Middle Aged
(17)
Aged
(11)
Medical And Health Sciences
(11)
Psychiatry
(11)
Clinical Medicine
(10)
Fundamental And Applied Biological Sciences. Psychology
(10)
Klinisk Medicin
(10)
Animals
(9)
Endocrinology & Metabolism
(9)
Double-Blind Method
(8)
Fluoxetine - Adverse Effects
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fluoxetine Treatment for Prevention of Relapse of Depression in Children and Adolescents: A Double-Blind, Placebo-Controlled Study

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression

Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia

Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment

Identifying Potential Adverse Events Dose-Response Relationships Via Bayesian Indirect and Mixed Treatment Comparison Models

Fluoxetine and adult suicidality revisited: an updated meta-analysis using expanded data sources from placebo-controlled trials

Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: An updated meta-analysis

Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study

Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day dose

No gender differences in placebo responses of patients with major depressive disorder

Defining Treatment-Emergent Adverse Events with the Medical Dictionary for Regulatory Activities (MedDRA)

Fluoxetine 40–60 mg versus Fluoxetine 20 mg in the Treatment of Children and Adolescents with a Less-Than-Complete Response to Nine-Week Treatment with Fluoxetine 10–20 mg: APilot Study

Interpreting melanin-based coloration through deep time: a critical review

Identification of Highly Active Fe Sites in (Ni,Fe)OOH for Electrocatalytic Water Splitting

GRK3 deficiency elicits brain immune activation and psychosis

Correction: GRK3 deficiency elicits brain immune activation and psychosis

Cardiometabolic Polygenic Risk Scores and Osteoarthritis Outcomes: A Mendelian Randomization Study Using Data From the Malmö Diet and Cancer Study and the UK Biobank

Allergen immunotherapy and/or biologicals for IgE‐mediated food allergy: A systematic review and meta‐analysis

PPARα is a key regulator of hepatic FGF21

A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes

Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults

Enhancing the alignment of the preclinical and clinical stroke recovery research pipeline: Consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable translational working group

Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia

Lymphocytes Contribute to the Pathophysiology of Neonatal Brain Injury

Murine astrotactins 1 and 2 have a similar membrane topology and mature via endoproteolytic cleavage catalyzed by a signal peptidase

Suchergebnisse filtern